全球领先的新经济产业第三方数据挖掘与分析机构
关于“神州细胞”的报告
艾媒咨询|2020年中国细胞生物产业和商业应用分析报告
本报告研究涉及企业/品牌/案例:华夏源、复星医药。
中国细胞生物产业类型呈现多样化趋势,细胞生物临床研究不断深化,伴随生态合作的拓展将进一步加速细胞生物产业生态圈的形成,生态圈的完善将在很大限度上推动产业快速发展。数据显示,中国细胞治疗企业融资金额不断增加,从2014年的0.2亿元增长至2019年的28.9亿元。其中,2018年中国细胞治疗企业融资额同比增长706.8%,呈现迅猛发展态势。未来中国细胞生物产业的发展将充满机遇,同时也有挑战并存。后续产业的发展,将在5G、人工智能等新技术应用下加速升级。面临多端变化的市场格局,企业也应积极开展生态合作以及更为密切关注市场需求动向,将疗法和新一代医疗创新技术深度融合,实现市场产品多元化与差异化,并推出独特性的精准治疗,从而最大限度地释放产业价值。
The types of cell biological industry in China show a trend of diversification, and the deepening of cell biological clinical research will further accelerate the formation of the cell biological industry ecosystem with the expansion of ecological cooperation, and the improvement of the ecosystem will promote the rapid development of the industry to a large extent. Data show that the financing amount of Chinese cell therapy enterprises keeps increasing, from 20 million yuan in 2014 to 2.89 billion yuan in 2019. Among them, in 2018, the financing amount of Chinese cell therapy enterprises increased by 706.8% year on year, showing a rapid development trend. In the future, the development of China's cell biology industry will be full of opportunities and challenges. The development of subsequent industries will be accelerated with the application of new technologies such as 5G and ARTIFICIAL intelligence. In the face of the changing market pattern, enterprises should also actively carry out ecological cooperation and pay close attention to the trend of market demand, deeply integrate therapy and new-generation medical innovation technology, realize the diversification and differentiation of market products, and launch unique precision therapy, so as to maximize the release of industrial value.艾媒报告 | 2017-2018中国网约专车行业市场研究报告
本报告研究涉及企业/品牌包括:滴滴专车、神州专车、易到用车、首汽约车、Gofun、Evcard、盼达用车、微公交、华夏出行、Car2go、立刻出行、一度出行、PonyCar、易开出行、嗨车、神州共享汽车、小二租车、摩范出行、支付宝、微信支付
iiMedia Research(艾媒咨询)数据显示,自2015年以来网约专车/快车用户规模迅速增长,到2017年用户规模达到2.36亿人,2018年有望达到2.82亿人。艾媒咨询分析师认为,随着人们生活品质的不断提高,其出行结构不断改变,而传统城市交通已逐渐不能满足用户需求,网约专车作为便捷灵活的出行新选择将会获得更大的发展。
- 1
- 2
- 3
- 4
- 5
- 6
- 19